Imexpharm (STC:IMP) Tax Provision: ₫-97,055 Mil (TTM As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
97 GF Score
Price ₫42,950.00
GF Value ₫52,260.37
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Tax Provision?

Imexpharm STC:IMP +0.59% 97 Tax Provision is ₫-97,055 Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 97/100 and a GF Value™ of ₫52,260.37 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Imexpharm's tax provision for the three months ended in Mar. 2026 was ₫-20,796 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was ₫-97,055 Mil.

Imexpharm Tax Provision Historical Data

* Premium members only.

The historical data trend for Imexpharm's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Tax Provision Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -49,764.22 -67,863.83 -77,716.93 -83,330.54 -97,109.72

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20,849.91 -24,558.69 -23,974.27 -27,726.85 -20,795.66
STC:IMP
97GF Score
Imexpharm Corp STC:IMP
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫-97,055 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of ₫-97,055 Mil mean?
Imexpharm (STC:IMP) has a Tax Provision of ₫-97,055 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Imexpharm and its competitors.
Is Imexpharm's Tax Provision too high?
Imexpharm's current Tax Provision is ₫-97,055 Mil. Overall, Imexpharm has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Tax Provision compare to ZTS and UTHR?
Imexpharm's Tax Provision of ₫-97,055 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Drug Manufacturers company?
A good Tax Provision depends on the Drug Manufacturers industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Imexpharm and its competitors. Imexpharm's current Tax Provision is ₫-97,055 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫52,260.37, compared to a current price of ₫42,950.00 — trading 17.8% below its estimated fair value. The current Tax Provision is ₫-97,055 Mil. Imexpharm's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Tax Provision is ₫-97,055 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,950.00 is trading 17.8% below its estimated GF Value™ of ₫52,260.37. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Tax Provision: ₫-97,055 Mil
  • GF Value™: ₫52,260.37 vs. price of ₫42,950.00 (17.8% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
97GF Score

Get the complete analysis for STC:IMP

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,950.00
Price
₫52,260.37
GF Value